Retrospective Review of Bioequivalence Studies on Losartan in Taiwan
碩士 === 臺北醫學大學 === 藥學研究所 === 98 === Bioequivalence (BE) study plays an important role on the approval of generic drugs and has been discussed on national and international for more than thirty years. To establish BE between generic and brand-name drug, appropriate study design and analytical method a...
Main Authors: | Chia-Shan Tsai, 蔡佳珊 |
---|---|
Other Authors: | Kuang-Yang Hsu |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/11910161391363921117 |
Similar Items
-
Expert Approaches to the Assessment of Losartan Drugs Bioequivalence
by: D. P. Romodanovsky, et al.
Published: (2020-02-01) -
Bioequivalent study of two Cefamandole formulations: Cefadol and Mandol
by: Cai, Hui-Shan, et al.
Published: (1996) -
Review of bioequivalence studies of cholecalciferol drugs
by: Alexander L. Khokhlov, et al.
Published: (2020-09-01) -
BIOEQUIVALENCE STUDIES
by: Mihajlo B Jakovljević, et al.
Published: (2006-10-01) -
A p-value approach to assessing In-vitro nonprofile bioequivalence
by: Wei-Shan Su, et al.
Published: (2002)